FSH and folliculogenesis: from physiology to ovarian stimulation (Q36515505)

14 August 2017

1 reference

title

FSH and folliculogenesis: from physiology to ovarian stimulation (English)

1 reference

14 August 2017

Walter Vegetti

1

1 reference

PubMed ID

16792843

14 August 2017

Federica Alagna

series ordinal

2

1 reference

14 August 2017

1 June 2006

1 reference

Reproductive BioMedicine Online

14 August 2017

1 reference

14 August 2017

12

1 reference

14 August 2017

6

1 reference

14 August 2017

684-694

1 reference

Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group

14 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

GnRH antagonist in assisted reproduction: a Cochrane review

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Meta-analysis of recombinant versus urinary-derived FSH: an update

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Outcome from consecutive assisted reproduction cycles in patients treated with recombinant follitropin alfa filled-by-bioassay and those treated with recombinant follitropin alfa filled-by-mass

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Pharmacodynamics of a single low dose of long-acting recombinant follicle-stimulating hormone (FSH-carboxy terminal peptide, corifollitropin alfa) in women with World Health Organization group II anovulatory infertility

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Continued improvements in the quality and consistency of follitropin alfa, recombinant human FSH.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

First live birth after ovarian stimulation using a chimeric long-acting human recombinant follicle-stimulating hormone (FSH) agonist (recFSH-CTP) for in vitro fertilization.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Gonadotropin-releasing hormone antagonist: new tools vs. old habits

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

First human exposure to FSH-CTP in hypogonadotrophic hypogonadal males

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Pituitary Control of Ovarian Function — Concepts Derived from Gonadotrophin Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Examination of the relative role of FSH and LH in the mechanism of ovulatory follicle selection in sheep

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Evaluating the role of exogenous luteinizing hormone in poor responders undergoing in vitro fertilization with gonadotropin-releasing hormone antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Updated meta-analysis of recombinant follicle-stimulating hormone (FSH) versus urinary FSH for ovarian stimulation in assisted reproduction

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

[In vitro fertilization in France: economic aspects and influence of the gonadotropin choice (urinary vs. recombinant) on cost]

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized cont

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Induction of multiple follicular development by a single dose of long-acting recombinant follicle-Stimulating hormone (FSH-CTP, corifollitropin alfa) for controlled ovarian stimulation before in vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

The use of a 100 IU starting dose of recombinant follicle stimulating hormone (Puregon) in in-vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Human follicle-stimulating hormone structure-activity relationships.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

FSH: what is the highest dose for ovarian stimulation that makes sense on an evidence-based level?

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Quantification of follicle stimulating hormone (follitropin alfa): is in vivo bioassay still relevant in the recombinant age?

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Single dose pharmacokinetics and effects on follicular growth and serum hormones of a long-acting recombinant FSH preparation (FSH-CTP) in healthy pituitary-suppressed females

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Respective efficacy of gonadotrophins should be the heart of the debate

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Extrapituitary effects of GnRH antagonists in assisted reproduction: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Follicle-stimulating hormone receptor polymorphisms in a population of infertile women

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Structure of human follicle-stimulating hormone in complex with its receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Design of a long-acting follitropin agonist by fusing the C-terminal sequence of the chorionic gonadotropin beta subunit to the follitropin beta subunit

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Manipulation of human ovarian function: physiological concepts and clinical consequences

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

To agonize or antagonize in gonadotrophin stimulation cycles?

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Hormone profiles under ovarian stimulation with human menopausal gonadotropin (hMG) and concomitant administration of the gonadotropin releasing hormone (GnRH)-antagonist Cetrorelix at different dosages.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

In vitro fertilization following natural cycles in poor responders

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Isolation, cloning and sequence analysis of the cDNA for the α-subunit of human chorionic gonadotropin

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Stimulation and growth of antral ovarian follicles by selective LH activity administration in women

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Three-dimensional structure of human follicle-stimulating hormone

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Superovulation with exogenous gonadotropins does not inhibit the luteinizing hormone surge

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Stimulatory Action of Gonadotropins and Prostaglandins on Adenosine-3′,5′-Monophosphate Production by Isolated Rat Granulosa Cells1

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

A common single nucleotide polymorphism in exon 10 of the human follicle stimulating hormone receptor is a major determinant of length and hormonal dynamics of the menstrual cycle

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Pharmacogenetics in ovarian stimulation - current concepts and future options

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

GnRH antagonists in ovarian stimulation: a treatment regimen of clinicians' second choice? Data from the German national IVF registry

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Improvement in consistency of response to ovarian stimulation with recombinant human follicle stimulating hormone resulting from a new method for calibrating the therapeutic preparation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Development and characterization of a long-acting recombinant hFSH agonist.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Pharmacokinetics and pharmacodynamics of single-chain recombinant human follicle-stimulating hormone containing the human chorionic gonadotropin carboxyterminal peptide in the rhesus monkey

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Exposure to high levels of luteinizing hormone and estradiol in the early follicular phase of gonadotropin-releasing hormone antagonist cycles is associated with a reduced chance of pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Recombinant gonadotrophins in reproductive medicine: gold standard for ovarian stimulation therapy in the 21st century

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Use of GnRH antagonists in ovarian stimulation for assisted reproductive technologies compared to the long protocol. Meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix (Cetrotide) in controlled ovarian stimulation for assisted reproduction.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Randomized trial to compare the effect of recombinant human FSH (follitropin alfa) with or without recombinant human LH in women undergoing assisted reproduction treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

The biological role of the carboxyl-terminal extension of human chorionic gonadotropin [corrected] beta-subunit

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Initial and Cyclic Recruitment of Ovarian Follicles

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Successful pregnancies with unstimulated cycle oocyte donation using an antagonist of gonadotropin-releasing hormone.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Pituitary response to exogenous LHRH in superovulated women

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Endocrine and follicle characteristics of cycles with and without endogenous luteinizing hormone surges during superovulation induction with pulsatile follicle-stimulating hormone

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Alternate day and daily administration of GnRH antagonist may prevent premature luteinization to a similar extent during FSH treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

A mutation in the follicle-stimulating hormone receptor as a cause of familial spontaneous ovarian hyperstimulation syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

A controlled trial of natural cycle versus microdose gonadotropin-releasing hormone analog flare cycles in poor responders undergoing in vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Avoiding multiple pregnancies in ART: evaluation and implementation of new strategies

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Addition of a gonadotropin releasing hormone (GnRH) antagonist and exogenous gonadotropins to unstimulated in vitro fertilization (IVF) cycles: physiologic observations and preliminary experience

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Minimal stimulation IVF with late follicular phase administration of the GnRH antagonist cetrorelix and concomitant substitution with recombinant FSH: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Efficacy of natural cycle IVF: a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Ovarian Response to Follicle-Stimulating Hormone (FSH) Stimulation Depends on the FSH Receptor Genotype

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Changes in the isoforms of luteinizing hormone and follicle-stimulating hormone during puberty in normal children.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Glycoprotein Hormones: Structure and Function

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Comparison of GnRH agonists and antagonists in assisted reproduction cycles of patients at high risk of ovarian hyperstimulation syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Cost-effectiveness of recombinant versus urinary follicle-stimulating hormone in assisted reproduction techniques in the Spanish public health care system

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Revival of the natural cycles in in-vitro fertilization with the use of a new gonadotrophin-releasing hormone antagonist (Cetrorelix): a pilot study with minimal stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Effects of long-acting recombinant human follicle-stimulating hormone analogs containing N-linked glycosylation on murine folliculogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Assay of the follicle stimulating hormone based on the augmentation with human chorionic gonadotropin.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Genetic and functional analyses of polymorphisms in the human FSH receptor gene

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Ovarian responses in women to recombinant follicle-stimulating hormone and luteinizing hormone (LH): a role for LH in the final stages of follicular maturation.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Differential effects of the charge variants of human follicle-stimulating hormone

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

New natural inactivating mutations of the follicle-stimulating hormone receptor: correlations between receptor function and phenotype.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Biochemical and functional aspects of gonadotrophin-releasing hormone and gonadotrophins

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Impact of Carbohydrate Heterogeneity in Function of Follicle-Stimulating Hormone: Studies Derived from in Vitro and in Vivo Models1

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Is there any physiological role for gonadotrophin oligosaccharide heterogeneity in humans? I. Gondatrophins are synthesized and released in multiple molecular forms. A matter of fact

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Role of glycosylation in function of follicle-stimulating hormone

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Biological characterization of the isoforms of urinary human follicle-stimulating hormone contained in a purified commercial preparation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Effectiveness of human menopausal gonadotropin versus recombinant follicle-stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive cycles: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

DNA sequence and regional assignment of the human follicle-stimulating hormone beta-subunit gene to the short arm of human chromosome 11

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Long-acting follicle-stimulating hormone analogs containing N-linked glycosylation exhibited increased bioactivity compared with o-linked analogs in female rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Follicle-stimulating hormones in anterior pituitary glands from children and adults differ in relation to sex and age

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

The regulation of metabolic clearance rate of human FSH in mice by variation of the molecular structure of the hormone.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Studies on the relative in-vitro biological potency of the naturally-occurring isoforms of intrapituitary follicle stimulating hormone

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Dynamics of basal and gonadotropin-releasing hormone-releasable serum follicle-stimulating hormone charge isoform distribution throughout the human menstrual cycle

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

The physiology of follicle selection

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

The Role of Gonadotropins in the Selection of the Preovulatory Follicle

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

Gonadotropin-Binding Sites in the Rhesus Monkey Ovary: Role of the Vasculature in the Selective Distribution of Human Chorionic Gonadotropin to the Preovulatory Follicle*

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961080-2

7 January 2021

10.1016/S1472-6483(10)61080-2

Identifiers

DOI

1 reference

14 August 2017

1 reference

PubMed ID

16792843